Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants
-
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels
-
Aprea Therapeutics Announces Strategic IP Portfolio Evolution in DNA Damage Response (DDR) Cancer Therapeutics
-
WillScot to Announce Fourth Quarter 2024 Results on February 20, 2025
-
Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20
-
Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer’s Disease
-
Systemic Bio Wins the SLAS 2025 Innovation Award
-
Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
-
Ultragenyx Announces New Data Demonstrating that Treatment with UX111 AAV Gene Therapy Significantly Improved Clinical Function Across Multiple Developmental Domains in Children with Sanfilippo Syndro
-
Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors
-
AXIL Brands to Debut its MX Series of Over-the-Ear Hearing Protection Products at NASCAR Daytona 500
-
ARS Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Conference
-
Stryker declares an $0.84 per share quarterly dividend
-
Collegium Appoints Nancy S. Lurker to its Board of Directors
-
R1 Wins ‘Best in KLAS’ Across Multiple RCM Categories for 2025
-
Health Catalyst to Announce Fourth Quarter and Full Year 2024 Operating Results and Host Conference Call on Wednesday, February 26, 2025
-
MIMEDX to Host Fourth Quarter and Full Year 2024 Operating and Financial Results Conference Call on February 26
-
PDS Biotech Reaffirms Guidance for First Quarter Initiation of VERSATILE-003 Phase 3 Clinical Trial in HPV16-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
-
Constellium to Report Fourth Quarter and Full Year 2024 Results on February 20, 2025
-
Erasmus Medical Center Safety Committee Grants Approval to Proceed with Phase 2 Study of Ampligen® and Imfinzi as a Potential Combination Therapy for Late-Stage Pancreatic Cancer
-
E-Star BioTech Announces Dosing of First Patient in Phase 2 Clinical Trials of MANP in Resistant Hypertension
-
TransUnion Introduces TruVision Alternative Bank Risk Score to Help Lenders Better Assess Consumers with Limited Credit Histories
-
Nextech Wins Two Best in KLAS Awards, Earning Top Honors in Dermatology and Ophthalmology
-
Lifeward Finalizes Personal Exoskeleton Reimbursement Agreement with BARMER, Adding 8.5 Million Covered Lives in Germany
-
Rhythm Pharmaceuticals to Present at Oppenheimer Annual Healthcare Life Sciences Conference in February
-
A New addition to the PureTech Toolbox: Integration with Echodyne’s EchoShield Radar for Enhanced Security and Counter-Drone Solutions
-
ChargeAfter Teams Up with Bread Financial to Offer Flexible Payment Options through its Embedded Lending Network
-
Uni-Fuels Announces Sponsorship for IBIA Annual Dinner 2025
-
Canon Medical and AHRA Celebrate Record-Breaking Success in Living Our Legacy Campaign
-
e-therapeutics to Present Preclinical Data on ETX-148 at EAHAD 2025
-
BitMEX Launches 20 New Altcoin Options Featuring LTC, SUI, LINK, and More
-
ParaZero Successfully Demonstrates its Precision Airdrop System with Leading Defense Company
-
American Rebel CEO Andy Ross to Appear on ABC-TV Tampa Weekday Morning Show Morning Blend
-
Nextracker Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Distri
-
Novacium’s Silicon-Anode Batteries Achieve 900+ Cycle Efficiency, Outperforming Leading 18650 Cells
-
Novo Nordisk files annual report with the SEC
-
Alliance Witan PLC - Net Asset Value
-
Brink’s Schedules Fourth-Quarter and Full Year 2024 Earnings Release and Conference Call for February 26, 2025
-
FirstService Reports Fourth Quarter and Full Year Results
-
Stallion Uranium Commences Ground Electromagnetic Survey on High Priority Drill Targets
-
Stock Yards Bancorp to Participate in the KBW Winter Financial Services Conference
-
American Tungsten Corp. Compiles Historical Drilling Data for IMA Mine Project in Idaho, USA
-
HydroGraph Achieves ISO 9001:2015 Certification, Strengthening Commitment to Quality Management
-
Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025
-
Hydreight Technologies Expands Telehealth Offerings with Launch of NAD+ Therapy on VSDHOne Platform
-
Man Group PLC : Form 8.3 - Spirent Communications plc
-
Man Group PLC : Form 8.3 - International Distribution Services plc
-
Scatec ASA – Successful placement of senior unsecured green bonds
-
Man Group PLC : Form 8.3 - Dowlais Group plc
-
Vishay Intertechnology Reports Fiscal Fourth Quarter and Full Year 2024 Results
